Neuroscience and Neuronal Disorders
Terms and conditions
Nov 17-18, 2025 Las Vegas, USA

International Conference onNeuroscience and Neuronal Disorders

Abstract Submission Deadline: Apr 23, 2025
Early Bird Registration End Date: Apr 25, 2025

Terms and Conditions

Thank you for choosing Sciconx Conferences. Please read the following terms and conditions carefully as they govern your reservation and participation in our events. Your reservation implies acceptance of these terms.

  • Submission of your online registration indicates your acceptance of Sciconx Conferences terms and conditions. Confirmation is subject to complete payment receipt, and a confirmation email with a receipt will be sent upon successful registration.
  • Full payment of registration fees is required before the event. Access to the conference will only be granted upon confirmation of complete payment.
  • All payment transactions, including credit/debit card payments, are securely processed through our online portal to safeguard your personal information.
  • By registering for a Sciconx conference, you agree to allow organizers to contact you via email, telephone, fax, or other available modes for event-related communication.
  • Personal information may be shared with third-party service providers involved in event execution. This data may also be shared with event partners and sponsors for relevant product and service communication.
  • Your personal information will not be disclosed to any third party without explicit consent, except as required by law.
  • Participants can opt out of such use of their details by contacting support@sciconx.com

General:

  • Cancellation and refund requests must be emailed to support@sciconx.com
  • Refunds will be issued after the conference concludes in the second week.
  • As stated in our registration terms and conditions, unfortunately, we are unable to process refunds once the official invitation letter has been completed.

Cancellation Charges

Registration fees:

  • 60 days or more before the event: Eligible for a full refund minus a 20% administration fee for each registration.
  • Within 45-60 days before the event: Eligible for a 50% refund.
  • Within 45 days of the conference: Not entitled to any refund.
  • E-Poster/virtual participation fees are non-refundable.
  • All discounted registrations are non-refundable.

Accommodation Cancellation

  • No refunds will be provided for accommodation fees.
  • Substitutions can be made at any time with written notification to Sciconx at least 30 days before the event.
  • Transfer of fully paid registrations to others within the same organization is allowed with substitute details provided.

Sciconx reserves the right to modify the program, venue, and timing. Attendees are responsible for any associated expenses or losses in case of postponement or date changes.

  • Views expressed by speakers, sponsors, and exhibitors are their own. Sciconx is not liable for advice or opinions expressed at the conference.
  • Sciconx is not responsible for direct or indirect loss or damage resulting from event services or data.

Attendees must arrange suitable insurance coverage for conference participation. Sciconx is not responsible for personal property loss or damage.

Photographs and video recordings may be taken for advertising purposes. Attendees who wish not to be filmed should inform organizers in writing before the conference.

  • Participants are responsible for fulfilling their visa requirements, and Sciconx cannot be held responsible for any visa-related issues.
  • In consideration of increased security measures, we urge all attendees to promptly commence their visa application process.
  • Sciconx Conferences will not engage in direct communication with embassies or consulates on behalf of visa applicants. It is crucial that all delegates or invitees apply specifically for a Business Visa. Your cooperation in this regard is highly valued.

Registrants are responsible for parking and transportation.

Press permission must be obtained from Sciconx before the conference. Media should not conduct interviews without written approval.

All event attendees, including speakers, sponsors, and exhibitors, are subject to these terms and conditions. Sciconx reserves the right to change conditions without prior notice, reviewing them periodically for regulatory compliance and conference improvements.

Latest News

U.S. health agency purge includes 10 lab heads at National Institute of Neurological Disorders and Stroke

2025-04-02 - 2025-04

Ten lab heads at the U.S. National Institute of Neurological Disorders and Stroke (NINDS) received layoff notices yesterday morning as part of a widespread purge across federal health agencies. The move follows an announcement last week from Robert F. Kennedy, Jr., secretary of the Department of Health and Human Services (HHS), who pledged to reorganize the department and eliminate 10,000 positions, including 1,200 across the National Institutes of Health (NIH).

The Transmitter spoke with six NIH employees, five of whom are at NINDS, who were not authorized to speak publicly about the matter and asked to remain anonymous for fear of retaliation. The notices were delivered by email to the following NINDS scientists: Miguel Holmgren, Steven Jacobson, Dorian McGavern, Joseph Mindell, Katherine Roche, David Sibley, Kenton Swartz, Susan Wray, Ling-Gang Wu and Richard Youle , three sources told The Transmitter. At least one other senior scientist at NINDS was also dismissed, one source adds.

Youle, who studies cell apoptosis and mitochondria damage, won the 2021 Breakthrough Prize in Life Sciences for his work showing that clearing the damaged organelles can help protect against Parkinson’s disease. Roche currently serves as secretary for the Society for Neuroscience. Her lab investigates synaptic plasticity changes that underlie neurodevelopmental conditions.

Inhibitory cells work in concert to orchestrate neuronal activity in mouse brain

2025-04-09 - 2025-04

The most comprehensive map to date of cell structure and function in the mouse cortex reveals a previously unappreciated level of coordination among inhibitory interneurons.
The study—one of 10 on the mouse connectome released today in the Nature family of journals—shows that interneurons carefully select the types of excitatory neurons they connect with. They also appear to work in teams, targeting the same type or types of excitatory neurons from different angles.
“Not only is there this remarkable specificity of inhibitory cells to a particular set of excitatory types, but even inhibitory cells that come from very different groups can share that specificity,” says Nuno Maçarico da Costa, associate investigator at the Allen Institute, who led the interneuron study.
To build the map, researchers recorded neuronal firing in a cubic micrometer of visual cortex as a mouse watched a video and ran on a treadmill. They then used electron microscopy to trace the 1,183 excitatory neurons, 164 inhibitory interneurons and more than 70,000 synapses that orchestrated the bursts of brain activity.
The interneuron analysis adds to mounting evidence that inhibitory cells working in concert are the true maestros of brain activity.
“I think the hints of a lot of what they’re saying have been coming in multiple ways, but the ability to get down to the ultrastructural level and look at it has been fantastic,” says Gord Fishell, professor of neurobiology at Harvard Medical School, who was not involved in the work.

Can Two Ancient Practices Unlock Our Mental Health Crisis?

2025-04-13 - 2025-04

When Sarah, a 42-year-old physician, found herself unable to sleep and constantly anxious after years of high-pressure work, she turned to an unexpected combination of practices. "I tried meditation apps for years with limited success," she recalls. "But after a guided psilocybin session followed by daily meditation, I experienced a clarity and peace I hadn't felt since childhood. I've been practicing for more than a year now, and the world feels like a different place."
Sarah's experience reflects a growing trend: Two ancient approaches to exploring the nature of human consciousness— meditation and psychedelics—are being combined in new "hybrid" interventions, and they may be even more effective when used together. The implications could transform not just how we treat mental illness, but how we live our everyday lives, and even how we understand the hidden potential of the human mind.

Virtual Cognitive Behavioral Therapy Can Boost Mental Health

2025-04-13 - 2025-04

The Center for Addiction and Mental Health (CAMH) in Toronto has reported that while mental illness accounts for roughly 10% of the disease burden in Ontario, it receives only 7% of health care dollars.
The over $1.5 billion shortage strains the system’s capacity to provide prompt assistance and effective care. Only half of Canadians undergoing a major depressive episode receive “potentially sufficient treatment.” One promising solution to increase the accessibility of mental health care is virtual therapy, such as virtual cognitive behavioural therapy (CBT).
CBT is a psychotherapy approach that attempts to change a person's behaviour and thinking patterns. It has gained widespread recognition for its effectiveness in addressing depression, anxiety disorders, eating disorders, and alcohol and substance use disorders. There are many techniques used in CBT. For example, a popular strategy used is role-playing exercises, which help individuals prepare for challenging interpersonal interactions, and exposure therapy, which involves confronting and managing fears and anxieties.
Currently, many individuals face significant obstacles when seeking therapy. The pandemic prompted a shift toward virtual therapy. And support for the modality has been growing.

Useful Links

Subscribe Now